Nuvectra Announces Cowen & Company Hosted Physician Panel on Spinal Cord Stimulation on March 29, 2017
March 27 2017 - 7:30AM
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical
device company, announced today that Cowen and Company and The Ruth
Group are hosting a physician panel on the spinal cord stimulation
market and the Algovita system. The event will feature discussions
with Jeffery Rowe, MD, and Brian Bannister, MD, and will be
moderated by Cowen medical technology analyst Josh Jennings, MD.
Event: |
Spinal Cord Stimulation
Physician Panel |
Date: |
Wednesday, March 29,
2017 |
Time: |
12:00 pm ET |
Location: |
Cowen and Company
Offices; 599 Lexington Ave, New York |
A webcast of the event will be available by
visiting the investor relations section of Nuvectra’s website at
www.nuvectramed.com.
If interested in attending the live event please
contact your Cowen sales representative or The Ruth
Group.
Participating
PhysiciansJeffery Rowe, MD is a
practicing physician at Main Line Spine in King of Prussia
Pennsylvania, a comprehensive care center for spine related
conditions and injuries. Dr. Rowe attended medical school at Saba
University School of Medicine. Upon completing medical school he
entered a General Surgery residency at Medical College of
Pennsylvania/Hahnemann University before beginning his Physical
Medicine and Rehabilitation residency at University of
Pennsylvania. Following residency he was fellowship trained in
Interventional Spine and Pain Medicine. Dr. Rowe is board certified
in Physical Medicine & Rehabilitation and in Pain Medicine. His
professional interests include the management of complex pain
related medical issues with minimally invasive injections through
trial and surgically implanted spinal cord stimulators.
Brian Bannister, MD is a
practicing physician at Progressive Pain Management in Monmouth
County, NJ, where he takes a multimodal approaches to pain control
using proven, innovative techniques, combined with compassionate
and individualized care. Dr. Bannister attended medical school at
the State University of New York, Upstate Medical University where
he also completed a Fellowship in Pain Management and his residency
in Clinical Anesthesiology. Dr. Bannister is board certified in
Anesthesiology.
About Nuvectra Corporation
Nuvectra™ is a neurostimulation company
committed to helping physicians improve the lives of people with
chronic neurological conditions. The Algovita® Spinal Cord
Stimulation (SCS) System is our first commercial offering and is CE
marked and FDA approved for the treatment of chronic pain of the
trunk and/or limbs. Our innovative technology platform also has
capabilities under development to support other neurological
indications such as sacral nerve stimulation (SNS), and deep brain
stimulation (DBS). In addition, our NeuroNexus subsidiary designs,
manufactures and markets leading-edge neural-interface technologies
for the neuroscience clinical research market. Visit the Nuvectra
website at www.nuvectramed.com.
Company Contacts:
Nuvectra Corporation
Walter Berger, Chief Operating Officer and Chief Financial Officer
(214) 474-3102
wberger@nuvectramed.com
Jennifer Armstrong, Media Relations
(214) 474-3110
jarmstrong@nuvectramed.com
Investor Contacts:
The Ruth Group
Nick Laudico
(646) 536-7030
nlaudico@theruthgroup.com
Zack Kubow
(646) 536-7020
zkubow@theruthgroup.com
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From Apr 2024 to May 2024
Nuvectra (NASDAQ:NVTR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Nuvectra Corporation (NASDAQ): 0 recent articles
More News Articles